drugset / Trial / NCT00381082

A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.

NCT00381082 ↗

Phase 2/3 Completed 152 enrolled Uniquest Pty Ltd Ego Pharmaceuticals · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Objective To compare the cure rates (defined as the complete absence of live lice, adults or nymphs, as diagnosed by wet-combing of three Australian approved head lice products for the treatment of primary school children with head lice infestation. The study design will be randomised and assessor-blind using three comparative parallel treatment groups. The study population will consist of Queensland state primary school children (up to Year 7) with live head lice (adults or nymphs) on the hair or scalp who have not used any head lice product in the four weeks prior to the study.

Timeline

Start
2004-09
Primary completion
—
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Banlice Mousse Aerosol Unknown — Topical
Subject KP24 Medicated Foam Unknown — Topical
Subject MOOV Head Lice Treatment Unknown — Topical

Indications